Speaker Profile
Biography
Kári Stefánsson, M.D., Dr. Med. founded deCODE in August 1996. Dr. Stefánsson was previously a professor of Neurology, Neuropathology and Neuroscience at Harvard University and Director of Neuropathology at Beth Israel Hospital in Boston, Massachusetts. From 1983 to 1993, he held faculty positions in Neurology, Neuropathology and Neurosciences at the University of Chicago. Dr. Stefánsson received his M.D. and Dr. Med. from the University of Iceland and is board-certified in neurology and neuropathology in the United States. Dr. Stefansson is recognized as a leading figure in human genetics. He has shaped deCODEs scientific approach and been actively engaged in leading its gene discovery work, serving as senior author on most of the companys publications in major scientific journals.
Talk
Human diversity begins in the diversity of the sequences of nucleotides in the genome but the environment and interactions between the environment and the sequence contribute significantly. I will discuss how blood proteomics in the context of sequence of the genome allows us to capture environmental impact on human diversity
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Edward Esplin, Invitae
- PMWC Award Ceremony
Pioneer Honoree: Michael Snyder, Stanford
Pioneer Honoree: Kári Stefánsson, deCode Genetics
- Keynote
- Kári Stefánsson, deCode Genetics - Genomic & Multiomic Intervention and Prevention of Disease: Colorectal Cancer
- Edward Esplin, Labcorp Genetics - From Genomics to Phenomics: Redefining Disease Prevention and Personalized Health
- Lee Hood, Phenome Health - Multi-omic Characterization of Cancer Development and Progression
Chair: Kathleen Barnes, Oxford Nanopore Tech
- Carol Greider, UCSC
- Orit Rozenblatt-Rosen, Genentech
- Emily Leproust, Twist Biosciences - Imaging and Data Strategies in the Human Tumor Atlas Network (HTAN)
- Sean Hanlon, NIH/HTAN
- Advanced Image Analysis and Data Integration in the Human BioMolecular Atlas Program (HuBMAP)
- Pinaki Sarder, University of Florida - Predicting Disease and Managing Health Through Wearables Technologies (PANEL)
Chair: Michael Snyder, Stanford
- Jessilyn Dunn, Duke
- Erin Rainaldi, Verily Health
- Noosheen Hashemi, January.ai
- Gil Levy, Assuta Ashdod Hospital - Harnessing Single-Cell Genomics for Precision Disease Intervention
- Michael Schnall-Levin, 10x Genomics - Multi-omic Interrogation of Organ Systems
Chair: Jessilyn Dunn, Duke
- Gloria Pryhuber, University of Rochester Medical Center
- Chenchen Zhu, Stanford
- Assaf Kacen, PromiseBio - Vision for Tomorrow: Pioneer Insights (Audience Qs)
Chair:Cindy Lawley, Olink
- Kári Stefánsson, deCode Genetics